• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 233/60 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms

Patent holdings for IPC class C07D 233/60

Total number of patents in this class: 413

10-year publication summary

30
21
27
23
26
23
30
17
14
14
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
BASF SE
20933
19
Antecip Bioventures II LLC
331
16
Tokyo Ohka Kogyo Co., Ltd.
1542
10
The University of British Columbia
1501
9
Cellix Bio Private Limited
52
7
Daicel Corporation
2344
7
British Columbia Cancer Agency Branch
192
6
vTv Therapeutics LLC
151
6
Novartis AG
10849
5
FUJIFILM Corporation
29367
5
Agency for Science, Technology and Research
3620
5
King Saud University
404
5
Kureha Corporation
1027
5
LG Energy Solution, Ltd.
14982
5
Hoffmann-La Roche Inc.
3418
4
Henkel AG & Co. KGaA
10572
4
UDC Ireland Limited
478
4
The United States Government AS represented by The Department of Veterans Affairs
1174
4
University of Pittsburgh - Of the Commonwealth System of Higher Education
3151
4
Nanjing Shijiang Medicine Technology Co., Ltd
26
4
Other owners 279